Reimagine Medical Affairs
Building successful medical affairs teams A successful medical affairs team bridges clinical development and commercial functions to drive the uptake of innovative medicines. It includes clinicians who understand the clinical context, and the barriers and opportunities to getting innovative medicines to patients. It balances a team of experienced people with access to external competencies to […]
Pharmaceutical Leadership: Requirements for Success
Leading pharmaceutical companies have one common denominator: they possess leaders who provide their organisation with a clear strategic focus to successfully deliver on their priorities. These leaders have the capacity to make bold decisions, navigate new challenges, and empower their teams to drive the organisation towards its goals. In this white paper, we take a […]
How R&D Teams Create Value from On-Market Products (MedNous)
Most pharma R&D organisations are defined and measured by how well they deliver new product innovation, which is often a high risk, high return endeavour. Yet such companies almost always have a second, highly important and sometimes underappreciated role: creating value from on market products. This article, published in MedNous, analyses the performance of these […]
How R&D Teams Create Value from On-Market Products
Most pharma R&D organisations are defined and measured by how well they deliver new product innovation, which is often a high risk, high return endeavour. Yet such companies almost always have a second, highly important and sometimes underappreciated role: creating value from on-market products. Some companies even avoid new product innovation entirely, but still have […]
How to Power Pharma and Biotech R&D with Sharp Commercial Insights
Pharmaceutical research and development (R&D) organisations and pre-revenue biotechs aim to discover and develop medicines that will make a meaningful difference to patients’ lives. Such medicines will be those that are ‘commercially’ successful, so ‘commercial insight’ is a must-have for any effective R&D effort. In this article we explore how pharma and biotech companies leverage […]
The Novasecta European MidPharma Report 2022
Europe is home to 97 ‘MidPharmas’ – companies that develop and commercialise pharmaceutical products, with €100m-€6bn annual revenue. In our seventh annual report into this sector, we examine how these companies thrive, explore the key lessons similar organisations can learn, and conclude with imperatives for the entire pharmaceutical and biotech ecosystem. What To Expect In […]
How European MidPharmas have Grown Profits (MedNous)
Europe is home to 85 mid-sized pharmaceutical companies (MidPharmas) that invest in developing and commercialising pharmaceutical products. Many of these companies have achieved impressive, upward-trending earnings before interest and tax (EBIT) margins in the last five years. The median EBIT margin of MidPharma is now comparable to that of the largest pharma companies and many […]
How Pharma Manages Organisational Complexity
The success of large pharmaceutical companies hinges on their ability to deliver innovative therapies to patients, which drives them to grow and diversify their portfolios. With more scale and diversity, organisational structures and decision-making processes become more complex. Pharma leaders can navigate organisational complexity in many ways, but two constants persist: maintaining a strategic focus […]
How European MidPharmas have Grown Profits
Europe is home to 85 mid-sized pharmaceutical companies (MidPharmas) that invest in developing and commercialising pharmaceutical products. Many of these companies have achieved impressive, upward-trending earnings before interest and tax (EBIT) margins in the last five years. The median EBIT margin of MidPharma is now comparable to that of the largest pharma companies and many […]
Five Imperatives For Strategic And Operational Excellence
As technological advances and competition in the pharmaceutical ecosystem accelerate, it is vital for companies to stay at the cutting edge. The leading pharmaceutical companies focus, move fast and move together. They embrace strategic and operational excellence. Why is strategic and operational excellence important? Pharmaceutical and biotech companies must optimise the effectiveness of the multiple […]